Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 542)
Posted On: 09/29/2021 12:07:45 AM
Post# of 36563
Posted By: Krilac
I disagree 100% with whoever said that the listing of NGIO will not have an effect on NUGX. This is actually a perfect arbitrage with an option built in on top of it since the company's management can combine the two companies (there are some interesting caveats built in but I WON't go into it because it would be complex and I believe a little involved) with an automatic conversion happening within 18 months where the 2 classes of shares become 1. So the real arbitrage is the cost of the time frame (ie what minimum guaranteed rate of return would I ask for an 18 month lockup) with an additional discount based on the underlying level of risk which is quite small since they are short NGIO and long NUGX. As such there should be significant interest to professional traders/arbitragers and I believe a literally shrinking discount between the two classes as time goes by and as we get nearer to the actual conversion date. Anyway the discount should certainly not be greater to 30-35% due to the extended time frame but that spread will narrow significantly as time passes by













(2)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site